The earnings call highlighted several positive developments, including strategic leadership hires, progress in Medicaid program engagement, and European market expansion. However, these were offset by a decline in net revenue and a continued net loss, resulting in a balanced view of the company's financial and operational status.

Company Guidance -

Q3 2025

During Sera Prognostics' second quarter fiscal year 2025 earnings call, the company provided several metrics and insights regarding its commercial progress and future plans. Sera is focusing on enhancing market awareness and is optimistic about publishing its full PRIME study results by the end of the year, which could further validate the efficacy of their PreTRM Test. The study indicates significant cost-saving potential, projecting Medicaid programs can save an average of $1,600 per member tested. The company is engaging with Medicaid pilot programs in states with high premature birth rates, aiming to sign 2 to 4 pilot programs in the coming months. Financially, Sera reported a net revenue of $17,000 for the quarter, a decrease from $24,000 in the same quarter of 2024, while total operating expenses remained flat at $9.3 million. The company has $108.5 million in cash, cash equivalents, and available-for-sale securities, expected to fund operations through 2028. Internationally, Sera is preparing for the European market, initially targeting the U.K., France, and Germany, with plans to submit for regulatory approval by early 2026 and begin implementation in mid-2026.

PRIME Study Results and Publications

Sera Prognostics is working towards the publication of their full PRIME study results in a peer-reviewed publication, with strong primary outcomes and compelling data demonstrating the efficacy of the PreTRM Test. The publication is expected before year-end.

Medicaid Program Engagement

Sera Prognostics is seeing notable traction in 2 states with above-average premature birth rates for Medicaid plan pilot programs and growing momentum in 2 additional states. They plan to sign 2 to 4 pilot programs within the next few months.

European Market Expansion

Sera Prognostics is preparing to commercialize the PreTRM Test in Europe, focusing initially on the U.K., France, and Germany, with plans to make a submission to regulatory agencies in early 2026.

Strategic Leadership Hires

Sera has made key strategic leadership hires, including Lee Anderson as Chief Commercial Officer and Chuck Hyde as Head of Market Access, to strengthen their commercial efforts and increase awareness among stakeholders.

Strong Cash Position

As of June 30, 2025, Sera Prognostics had cash, cash equivalents, and available-for-sale securities of approximately $108.5 million, expected to fund the company through significant commercial milestones through 2028.

Sera Prognostics (SERA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SERA Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	-0.20 / -	-0.24	―	―	―
Aug 06, 2025	2025 (Q2)	-0.23 / -0.16	-0.25	36.00% (+0.09)	―
May 07, 2025	2025 (Q1)	-0.23 / -0.20	-0.25	20.00% (+0.05)	―
Mar 19, 2025	2024 (Q4)	-0.24 / -0.25	-0.25	0.00% (0.00)	―
Nov 06, 2024	2024 (Q3)	-0.22 / -0.24	-0.23	-4.35% (>-0.01)	―
Aug 07, 2024	2024 (Q2)	-0.26 / -0.25	-0.34	26.47% (+0.09)	―
May 08, 2024	2024 (Q1)	-0.27 / -0.25	-0.34	26.47% (+0.09)	―
Mar 20, 2024	2023 (Q4)	-0.26 / -0.25	-0.31	19.35% (+0.06)	―
Nov 08, 2023	2023 (Q3)	-0.34 / -0.23	-0.35	34.29% (+0.12)	―
Aug 09, 2023	2023 (Q2)	-0.36 / -0.34	-0.37	8.11% (+0.03)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

SERA Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 06, 2025	$2.75	$2.60	-5.45%
May 07, 2025	$2.40	$2.12	-11.67%
Mar 19, 2025	$4.14	$3.93	-5.07%
Nov 06, 2024	$8.74	$7.63	-12.70%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sera Prognostics (SERA) report earnings?

Sera Prognostics (SERA) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).

What is Sera Prognostics (SERA) earnings time?

Sera Prognostics (SERA) earnings time is at Nov 05, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is SERA EPS forecast?

SERA EPS forecast for the fiscal quarter 2025 (Q3) is -0.2.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing